This product requires a doctor's consultation.

Semaglutide is a GLP-1 receptor agonist indicated for the treatment of obesity and type 2 diabetes. It mimics the body’s natural glucagon-like peptide-1 hormone, helping regulate appetite, insulin secretion, and glucose metabolism. Under medical supervision, it supports significant, sustained weight reduction and improved metabolic health.

Benefits

Reduces appetite and prolongs satiety
Promotes clinically significant weight loss
Improves glycemic control and insulin sensitivity
May lower cardiovascular risk in adults with obesity or type 2 diabetes

Estimated duration: 15 weeks following standard titration: 0.25mg weekly for weeks 1-4, 0.5mg weekly for weeks 5-8, 1.0mg weekly for weeks 9-12, 1.7mg weekly for weeks 13-16

You may also like